Michael Schwarzschild, MD
Enriched profileJulieanne Dorn Professor of Neurology, Harvard Medical School; Staff Neurologist, Massachusetts General Hospital · Massachusetts General Hospital
Michael Schwarzschild is Julieanne Dorn Professor of Neurology, Harvard Medical School; Staff Neurologist, Massachusetts General Hospital at Massachusetts General Hospital. OpenAlex indexes 348 publications with 24,997 citations (h-index 86); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 16 Oct 2026
Michael Schwarzschild, MD PHD, is Julieanne Dorn Professor of Neurology, Harvard Medical School at Massachusetts General Hospital. The public record shows 348 publications with 24,997 citations (h-index 86), centered on Parkinson's Disease Mechanisms and Treatments, Adenosine and Purinergic Signaling, Neurological disorders and treatments. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 2 companies, 22 NIH-funded awards (1994–2026).
- Most recent indexed publication: 2026 · Journal of Parkinson's disease
- Top research focus: Parkinson's Disease Mechanisms and Treatments
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 225.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials
Sponsor: Massachusetts General Hospital
- Study of Urate Elevation in Parkinson's Disease, Phase 3
Sponsor: Michael Alan Schwarzschild
- Safety of Urate Elevation in Parkinson's Disease
Sponsor: The Parkinson Study Group
Industry payments
Updated 16 Oct 2026
2 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- UCB SAProgram year20241 payment$14,947openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20211 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Aromatic Amino Acid Decarboxylation Inhibitor74.2%Carbidopa-Levodopa52%Carbidopa-Levodopa Er36%Carbidopa-Levodopa-Entacapone7%Rytary5%Part D<11 patientsCatechol-O-Methyltransferase Inhibitor14.5%Entacapone86%Ongentys14%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
22 NIH research awards on record, funded 1994–2026 per NIH RePORTER. The latest:
- Planning for Prevention of Parkinson's Disease and Related Synucleinopathies: A trial design forum
Massachusetts General Hospital
FY2026$15,000R13NS147887 - Urate-LRRK2 interactions in Parkinson's disease
Massachusetts General Hospital
FY2023$385,473R01NS110879 - Planning for Prevention of Parkinson's Disease: a trial design forum
Massachusetts General Hospital
FY2023$60,000R13FD008015
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Preparing for Parkinson's disease prevention trials: Current progress and future directions.
Journal of Parkinson's disease
Review2026 - Soluble immune factor profiles in blood and CSF associated with LRRK2 mutations and Parkinson's disease.
NPJ Parkinson's disease
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/michael-schwarzschild-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
researchers.mgh.harvard.edu/profile/841380/Michael-Schwarzschild
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchers.mgh.harvard.edu ↗ - ResearchGate
researchgate.net/profile/Michael-Schwarzschild
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
hstalks.com/expert/2627/dr-michael-schwarzschild
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hstalks.com ↗ - Other
parkinson.org/library/podcast/79
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkinson.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org ↗
- PhD in Neuroscience
Harvard Medical School (thesis on neurochemistry of tyrosine hydroxylase)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - AB in Biochemistry
Princeton University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkinson-study-group.org ↗
- Director
Molecular Neurobiology Laboratory, MGH/MassGeneral Institute for Neurodegenerative Disease
1996verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Staff neurologist
weekly movement disorders clinic, MGH Department of Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
Awards & honors
honors on the public record- Cotzias Fellowship
American Parkinson's Disease Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
Secondary affiliations
appointments beyond the home institution- MassGeneral Institute for Neurodegenerative Disease (MIND)
Director, Molecular Neurobiology Laboratory
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Harvard Medical School
Department of Neurology (faculty appointment)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tcrpd.org ↗
Media & interviews
press, podcasts and appearances- Guest
"Substantial Matters" podcast (Parkinson's Foundation), Episode 79: "How Clinical Studies Help People with PD"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkinson.org ↗ - Featured profile
"Job Spotlight: Dr. Michael Schwarzschild, Neurologist at Massachusetts General Hospital, Highlights the Importance of Collaboration and Having Fun", The Science Explorer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thescienceexplorer.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida